AU1100388A - Protection against aminoglycoside-induced nephrotoxicity - Google Patents
Protection against aminoglycoside-induced nephrotoxicityInfo
- Publication number
- AU1100388A AU1100388A AU11003/88A AU1100388A AU1100388A AU 1100388 A AU1100388 A AU 1100388A AU 11003/88 A AU11003/88 A AU 11003/88A AU 1100388 A AU1100388 A AU 1100388A AU 1100388 A AU1100388 A AU 1100388A
- Authority
- AU
- Australia
- Prior art keywords
- protection against
- induced nephrotoxicity
- against aminoglycoside
- aminoglycoside
- nephrotoxicity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94722786A | 1986-12-29 | 1986-12-29 | |
| US947227 | 1986-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1100388A true AU1100388A (en) | 1988-07-27 |
Family
ID=25485774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU11003/88A Abandoned AU1100388A (en) | 1986-12-29 | 1987-12-21 | Protection against aminoglycoside-induced nephrotoxicity |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0294462A4 (en) |
| JP (1) | JPH01502268A (en) |
| AU (1) | AU1100388A (en) |
| WO (1) | WO1988004925A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995013818A1 (en) * | 1993-11-15 | 1995-05-26 | Baker Medical Research Institute | A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5079234A (en) * | 1989-03-23 | 1992-01-07 | Bristol-Myers Squibb Co. | Inhibitors of aminoglycoside nephrotoxicity |
| US6140309A (en) * | 1996-03-12 | 2000-10-31 | University Of South Florida | Vasoactive effects and free radical generation by β-amyloid peptides |
| US6933104B1 (en) | 1999-04-23 | 2005-08-23 | Shiva Biomedical, Llc | Diagnosis and treatment of human kidney diseases |
| JP2001335503A (en) * | 2000-05-29 | 2001-12-04 | Teika Seiyaku Kk | Radical scavenging drug |
| US7345018B2 (en) | 2002-04-25 | 2008-03-18 | Reception Aps | Method of treating side effects induced by therapeutic agents |
| CA2576190A1 (en) * | 2004-08-06 | 2006-02-16 | Shiva Biomedical, Llc | Iron chelators for treating radiocontrast-associated renal dysfunction |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1040635A (en) * | 1964-05-12 | 1966-09-01 | Ici Ltd | Antimycobacterial compositions |
| JPS5492951A (en) * | 1977-12-29 | 1979-07-23 | Shionogi & Co Ltd | Novel aminoglycoside derivative |
| GB2117237B (en) * | 1982-03-29 | 1985-07-24 | Orvet Bv | Paromomycin compositions for topical treatment of cutaneous leishmaniasis |
-
1987
- 1987-12-21 AU AU11003/88A patent/AU1100388A/en not_active Abandoned
- 1987-12-21 JP JP88501216A patent/JPH01502268A/en active Pending
- 1987-12-21 EP EP19880900666 patent/EP0294462A4/en not_active Withdrawn
- 1987-12-21 WO PCT/US1987/003468 patent/WO1988004925A1/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995013818A1 (en) * | 1993-11-15 | 1995-05-26 | Baker Medical Research Institute | A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1988004925A1 (en) | 1988-07-14 |
| EP0294462A4 (en) | 1990-01-23 |
| JPH01502268A (en) | 1989-08-10 |
| EP0294462A1 (en) | 1988-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU591007B2 (en) | 3-aryloxy-3-substituted propanamines | |
| AU556238B3 (en) | Multi-seasoning distributor | |
| AU6849687A (en) | Antimicrobial n-acyl-2-azetidinones | |
| AU593093B2 (en) | Radio-direction-finding | |
| AU7661587A (en) | Security arrangement | |
| AU7024087A (en) | Groundsheet | |
| AU6628986A (en) | Tots-in-tandem | |
| AU8261487A (en) | Medicaments | |
| AU7294187A (en) | Novel biocides | |
| AU6810287A (en) | Long acting formulation | |
| AU2750588A (en) | Anthelmintic compositions | |
| AU6925587A (en) | Naphthothiazepinones | |
| AU7446087A (en) | Transient protection device | |
| AU6800887A (en) | Fungicidal compositions | |
| AU5988990A (en) | 3-alkoxy-2-aminopropylamides | |
| AU1100388A (en) | Protection against aminoglycoside-induced nephrotoxicity | |
| AU6997187A (en) | Cell protection | |
| AU6876687A (en) | Theft-deterring label-holders | |
| AU579047B2 (en) | Pyridopyrimidinediones | |
| AU626472B2 (en) | 1-n-dodecylazacycloheptane-2-thione | |
| AU7182187A (en) | 3-carbamoyl-4-hydroxy-coumarins | |
| AU600015B2 (en) | Stacker | |
| AU6791287A (en) | Sky-light | |
| AU1100588A (en) | Protective wrapping | |
| AU6804587A (en) | 4-aminomethyl-fluoresceins |